Diet-induced obesity potentiates the growth of gastric cancer in mice

Experimental and Therapeutic Medicine

Volumn 4, Issue 4, 2012, Pages 615-620

  Li, Hai Jun ^a   Che, Xiang Ming ^a   Zhao, Wei ^a   He, Shi Cai ^a   Zhang, Zheng Liang ^b   Chen, Rui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Adipocytokine; Gastric cancer; Insulin resistance; Obesity; Visfatin

Indexed keywords

GLUCOSE; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CARCINOMA CELL; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DIET; FORESTOMACH; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INOCULATION; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; STOMACH CANCER; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84865375235     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.657     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J and PisaniP: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Brenner H, Rothenbacher D and ArndtV: Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477, 2009.
3. FormanD and BurleyVJ: Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 20: 633-649, 2006.
4. Flegal KM, CarrollMD, KitBK and OgdenCL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497, 2012.
5. Tilg H and MoschenAR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783, 2006.
6. CalleEE and KaaksR: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer4: 579-591, 2004.
7. Yang P, Zhou Y, Chen B, Wan HW, JiaGQ, BaiHL and WuXT: Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer 45: 2867-2873, 2009.
8. Yakar S, Nunez NP, PennisiP, et al: Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 147: 5826-5834, 2006.
9. Qian SS, Gao J, Wang JX, LiuY and DongHY: Establishment of a mouse forestomach carcinoma cell line (MFC) with spontaneous hematogenous metastasis and preliminary study of its biological characteristics. Zhonghua Zhong Liu Za Zhi 9: 261-264, 1987 (InChinese).
10. Zyromski NJ, Mathur A, PittHA, et al: Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 146: 258-263, 2009.
11. Kitayama J, Tabuchi M, Tsurita G, IshikawaM, OtaniK and NagawaH: Adiposity and gastrointestinal malignancy. Digestion 79: 26-32, 2009.
12. Kitayama J, Hatano K, KaisakiS, SuzukiH, FujiiS and NagawaH: Hyperlipidaemia is positively correlated with lymph node metastasis in men with early gastric cancer. Br J Surg 91: 191-198, 2004.
13. Moriwaki Y, Kunisaki C, Kobayashi S, Harada H, ImaiS and KasaokaC: Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy? Hepatogastroenterology 50: 284-288, 2003.
14. Ojima T, Iwahashi M, NakamoriM, et al: Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: an analysis of 689 consecutive cases managed by a single center. Arch Surg 144: 351-358, 2009.
15. Payer J, Jackuliak P and NagyováM: Obesity and a risk of carcinoma. Vnitr Lek 56: 1082-1087, 2010 (In Slovak).
16. Pollak M: Insulin-like growth factor-related signaling and cancer development. Recent Results Cancer Res 174: 49-53, 2007.
17. Samal B, Sun Y, Stearns G, XieC, SuggsS and McNieceI: Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14: 1431-1437, 1994.
18. Fukuhara A, Matsuda M, Nishizawa M, et al: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430, 2005.
19. Kim SR, Park HJ, BaeYH, et al: Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion. Endocrinology 153: 554-563, 2012.
20. Kim JG, Kim EO, Jeong BR, et al: Visfatin stimulates proliferation of MCF-7 human breast cancer cells. Mol Cells 30: 341-345, 2010.
21. Patel ST, Mistry T, Brown JE, Digby JE, Adya R, DesaiKM and RandevaHS: A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis. Peptides 31: 51-57, 2010.
22. Bi TQ and Che XM: Nampt/PBEF/visfatin and cancer. Cancer Biol Ther 10: 119-125, 2010.
23. Reddy PS, Umesh S, ThotaB, et al: PBEF1/NAmPRTase/visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value. Cancer Biol Ther 7: 663-668, 2008.
24. Nakajima TE, Yamada Y, HamanoT, et al: Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol 44: 685-690, 2009.
25. Nakajima TE, Yamada Y, HamanoT, et al: Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 101: 1286-1291, 2010.
26. Zhang Y, Daquinag A, TraktuevDO, et al: White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 69: 5259-5266, 2009.
27. Zhang Y, BellowsCF and KoloninMG: Adipose tissue-derived progenitor cells and cancer. World J Stem Cells 2: 103-113, 2010.
28. ComoglioPM and TrusolinoL: Cancer: the matrix is now in control. Nat Med 11: 1156-1159, 2005.